A phase II study, performed over a period of approximately 20 months, - Trial 2014-004515-37
Access comprehensive clinical trial information for 2014-004515-37 through Pure Global AI's free database. This phase not specified trial is sponsored by Novartis Vaccines and Diagnostics and is currently status unknown. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2014-004515-37
Trial Details
EU Clinical Trials Register • 2014-004515-37
A phase II study, performed over a period of approximately 20 months,
Study Focus
Sponsor & Location
Novartis Vaccines and Diagnostics
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
1. Number of Subjects Who Responded to Two or Three Vaccinations of the Fluad-H5N1 Influenza Vaccine.
ICD-10 Classifications
Influenza and pneumonia
Influenza due to identified seasonal influenza virus
Influenza with other manifestations, seasonal influenza virus identified
Influenza with pneumonia, seasonal influenza virus identified
Influenza due to identified zoonotic or pandemic influenza virus
Data Source
EU Clinical Trials Register
2014-004515-37
Non-Device Trial